| scholarly article | Q13442814 |
| P50 | author | Washington Cárdenas | Q42863713 |
| P2093 | author name string | Christopher F Basler | |
| Adrian T Ting | |||
| Akihiko Komuro | |||
| Aylwin Ng | |||
| Constantin S Friedman | |||
| Curt M Horvath | |||
| Diana Legarda-Addison | |||
| Jacob S Yount | |||
| Marie Anne O'Donnell | |||
| Ramnik Xavier | |||
| Thomas M Moran | |||
| P2860 | cites work | A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter | Q24306678 |
| Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif | Q24554502 | ||
| TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity | Q28118562 | ||
| Identification of the familial cylindromatosis tumour-suppressor gene | Q28145560 | ||
| IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway | Q28190704 | ||
| Triggering the interferon antiviral response through an IKK-related pathway | Q28191761 | ||
| CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members | Q28201693 | ||
| Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB | Q28201706 | ||
| The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination | Q28201717 | ||
| NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway | Q28269436 | ||
| Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK | Q28290460 | ||
| Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity | Q28290992 | ||
| Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling | Q28588278 | ||
| Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity | Q29615913 | ||
| Cell type-specific involvement of RIG-I in antiviral response | Q29615914 | ||
| Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction | Q29620054 | ||
| Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. | Q34545737 | ||
| Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling | Q34648134 | ||
| A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways | Q36089051 | ||
| Connecting mitochondria and innate immunity | Q36249270 | ||
| Immunity by ubiquitylation: a reversible process of modification | Q36328809 | ||
| The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene | Q38324299 | ||
| The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways | Q40139227 | ||
| Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. | Q40348165 | ||
| Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). | Q41186845 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein K63-linked deubiquitination | Q21100454 |
| CYLD lysine 63 deubiquitinase | Q21117462 | ||
| P304 | page(s) | 930-6 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | EMBO Reports | Q5323356 |
| P1476 | title | The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response | |
| P478 | volume | 9 |
| Q37076380 | A Hierarchical Mechanism of RIG-I Ubiquitination Provides Sensitivity, Robustness and Synergy in Antiviral Immune Responses |
| Q34945431 | A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses |
| Q38857831 | A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response |
| Q28596603 | A non-canonical role of the p97 complex in RIG-I antiviral signaling |
| Q24306232 | A novel function of human Pumilio proteins in cytoplasmic sensing of viral infection |
| Q34187000 | A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection |
| Q35378142 | ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling |
| Q34695889 | ARF-like protein 16 (ARL16) inhibits RIG-I by binding with its C-terminal domain in a GTP-dependent manner |
| Q38736590 | ARRDC4 regulates enterovirus 71-induced innate immune response by promoting K63 polyubiquitination of MDA5 through TRIM65. |
| Q35783875 | Activation of RIG-I-like receptor signal transduction |
| Q24305205 | Ankrd17 positively regulates RIG-I-like receptor (RLR)-mediated immune signaling |
| Q54219640 | Broad and diverse mechanisms used by deubiquitinase family members in regulating the type I interferon signaling pathway during antiviral responses. |
| Q38788570 | CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection |
| Q64258937 | CARMA3: Scaffold Protein Involved in NF-κB Signaling |
| Q90415771 | CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis |
| Q50292049 | CYLD mediated deubiquitination of DDX58 (RIG-I) |
| Q34584522 | CYLD regulates RhoA activity by modulating LARG ubiquitination |
| Q39210955 | CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different |
| Q37846231 | CYLD: a deubiquitination enzyme with multiple roles in cancer. |
| Q37448141 | CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes |
| Q30373058 | Casein kinase II controls TBK1/IRF3 activation in IFN response against viral infection. |
| Q28584927 | Caspase 8 inhibits programmed necrosis by processing CYLD |
| Q39437743 | Conventional protein kinase C-α (PKC-α) and PKC-β negatively regulate RIG-I antiviral signal transduction |
| Q34152661 | Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling |
| Q40860628 | Cytoplasmic STAT4 Promotes Antiviral Type I IFN Production by Blocking CHIP-Mediated Degradation of RIG-I. |
| Q39195781 | Cytosolic nucleic acid sensors and innate immune regulation |
| Q26852473 | Cytosolic sensing of viruses |
| Q35788640 | DYRK2 Negatively Regulates Type I Interferon Induction by Promoting TBK1 Degradation via Ser527 Phosphorylation |
| Q37814068 | Deubiquitinases in the regulation of NF-κB signaling |
| Q48265884 | Deubiquitylating enzymes and drug discovery: emerging opportunities. |
| Q39243745 | Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors |
| Q34261757 | Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. |
| Q40476073 | E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1. |
| Q37990630 | Emerging role of ubiquitination in antiviral RIG-I signaling |
| Q92218941 | Enteroviruses: A Gut-Wrenching Game of Entry, Detection, and Evasion |
| Q39789708 | Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication. |
| Q37816941 | Expanding role of ubiquitination in NF-κB signaling |
| Q28507375 | FLN29 deficiency reveals its negative regulatory role in the Toll-like receptor (TLR) and retinoic acid-inducible gene I (RIG-I)-like helicase signaling pathway |
| Q24632537 | Function and regulation of retinoic acid-inducible gene-I |
| Q35190533 | Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity |
| Q37252761 | Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3. |
| Q39092892 | Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity |
| Q92547172 | Human Hemoglobin Subunit Beta Functions as a Pleiotropic Regulator of RIG-I/MDA5-Mediated Antiviral Innate Immune Responses |
| Q24304438 | Immune signaling by RIG-I-like receptors |
| Q38722676 | Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway |
| Q29042349 | Induction of type I interferon by RNA viruses: cellular receptors and their substrates |
| Q40135920 | Influenza A virus-induced downregulation of miR-26a contributes to reduced IFNα/β production. |
| Q59350241 | Innate responses to gene knockouts impact overlapping gene networks and vary with respect to resistance to viral infection |
| Q38326249 | Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication. |
| Q91890873 | Intracellular sensing of viral genomes and viral evasion |
| Q35003295 | Intrinsic and extrinsic regulation of innate immune receptors |
| Q38075370 | IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer |
| Q28262399 | Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3 |
| Q58796111 | Kisspeptin/GPR54 signaling restricts antiviral innate immune response through regulating calcineurin phosphatase activity |
| Q28084011 | LGP2 synergy with MDA5 in RLR-mediated RNA recognition and antiviral signaling |
| Q34760296 | Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction |
| Q34593916 | Lysine 63-linked TANK-binding kinase 1 ubiquitination by mindbomb E3 ubiquitin protein ligase 2 is mediated by the mitochondrial antiviral signaling protein |
| Q24316163 | MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signaling |
| Q24297023 | MIP-T3 is a negative regulator of innate type I IFN response |
| Q52624830 | MLL5 suppresses antiviral innate immune response by facilitating STUB1-mediated RIG-I degradation. |
| Q38803414 | Manipulation of viral infection by deubiquitinating enzymes: new players in host-virus interactions |
| Q24337463 | Mapping a dynamic innate immunity protein interaction network regulating type I interferon production |
| Q39611090 | Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein |
| Q35886583 | Mechanisms and pathways of innate immune activation and regulation in health and cancer |
| Q38258737 | Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors |
| Q24316185 | Mitochondrially localised MUL1 is a novel modulator of antiviral signaling |
| Q37863124 | Mitochondrion: an emerging platform critical for host antiviral signaling |
| Q38939998 | Multilayered regulations of RIG-I in the anti-viral signaling pathway |
| Q34426832 | NEMO binds ubiquitinated TANK-binding kinase 1 (TBK1) to regulate innate immune responses to RNA viruses. |
| Q36120074 | NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1. |
| Q34877184 | NF-κB/Rel proteins and the humoral immune responses of Drosophila melanogaster |
| Q36687828 | NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis |
| Q28116012 | Negative regulation of RIG-I-mediated innate antiviral signaling by SEC14L1 |
| Q38080338 | Negative regulation of TBK1-mediated antiviral immunity |
| Q27487296 | Negative regulation of cytoplasmic RNA-mediated antiviral signaling |
| Q28478468 | Negative regulation of interferon-β gene expression during acute and persistent virus infections |
| Q34958610 | Negative regulation of melanoma differentiation-associated gene 5 (MDA5)-dependent antiviral innate immune responses by Arf-like protein 5B |
| Q92188802 | Novel TMEM173 Mutation and the Role of Disease Modifying Alleles |
| Q36246350 | ORF45 of Kaposi's sarcoma-associated herpesvirus inhibits phosphorylation of interferon regulatory factor 7 by IKKε and TBK1 as an alternative substrate |
| Q24300481 | Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection |
| Q35617725 | Optineurin regulates the interferon response in a cell cycle-dependent manner |
| Q59356706 | PLA1A Participates in the Antiviral Innate Immune Response by Facilitating the Recruitment of TANK-Binding Kinase 1 to Mitochondria |
| Q47555868 | Paramyxovirus V proteins interact with the RIG-I/TRIM25 regulatory complex and inhibit RIG-I signaling |
| Q39013521 | Post-translational Control of Intracellular Pathogen Sensing Pathways |
| Q39458855 | Post-translational regulation of antiviral innate signaling. |
| Q41935577 | Posttranslational Modification Control of Inflammatory Signaling |
| Q39374120 | Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition. |
| Q24315750 | REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I |
| Q37939129 | RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. |
| Q28081647 | RIG-I-like receptor regulation in virus infection and immunity |
| Q37925067 | RIG-I-like receptors: cytoplasmic sensors for non-self RNA. |
| Q39358994 | RIG-I: a multifunctional protein beyond a pattern recognition receptor |
| Q34545358 | RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. |
| Q40696614 | RNF123 has an E3 ligase-independent function in RIG-I-like receptor-mediated antiviral signaling. |
| Q90058672 | RNF144B inhibits LPS-induced inflammatory responses via binding TBK1 |
| Q97519103 | Recent Advances and Contradictions in the Study of the Individual Roles of Ubiquitin Ligases That Regulate RIG-I-Like Receptor-Mediated Antiviral Innate Immune Responses |
| Q36474924 | Receptor-Interacting Protein Kinase-2 Inhibition by CYLD Impairs Antibacterial Immune Responses in Macrophages |
| Q38078138 | Recognition of pathogen-associated nucleic acids by endosomal nucleic acid-sensing toll-like receptors |
| Q38054048 | Recognition of viruses in the cytoplasm by RLRs and other helicases--how conformational changes, mitochondrial dynamics and ubiquitination control innate immune responses |
| Q24307162 | Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity |
| Q38229327 | Regulation of RIG-I-like receptor signaling by host and viral proteins |
| Q35534397 | Regulation of antiviral innate immunity by deubiquitinase CYLD. |
| Q38042201 | Regulation of the innate immune system by ubiquitin and ubiquitin-like modifiers |
| Q33717393 | Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. |
| Q90670400 | Regulation of virus-triggered type I interferon signaling by cellular and viral proteins |
| Q92822402 | Regulatory interplay between deubiquitinating enzymes and cytokines |
| Q97692983 | Remodeling without destruction: non-proteolytic ubiquitin chains in neural function and brain disorders |
| Q36922870 | Retinoic acid inducible gene-I, more than a virus sensor |
| Q89555530 | Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL) |
| Q36146429 | Ring finger protein 166 potentiates RNA virus-induced interferon-β production via enhancing the ubiquitination of TRAF3 and TRAF6. |
| Q24294664 | SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation |
| Q35764207 | SOCS3 Drives Proteasomal Degradation of TBK1 and Negatively Regulates Antiviral Innate Immunity |
| Q38681728 | Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease |
| Q41694897 | Stratified ubiquitination of RIG-I creates robust immune response and induces selective gene expression. |
| Q27674485 | Structure and Dynamics of the Second CARD of Human RIG-I Provide Mechanistic Insights into Regulation of RIG-I Activation |
| Q39381317 | Structure and Function of Viral Deubiquitinating Enzymes. |
| Q37393387 | Structure and ubiquitination-dependent activation of TANK-binding kinase 1. |
| Q37000243 | Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD. |
| Q38936007 | Systems-based analysis of RIG-I-dependent signalling identifies KHSRP as an inhibitor of RIG-I receptor activation. |
| Q33832484 | TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases |
| Q30491128 | TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma |
| Q39001917 | TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination |
| Q37617439 | The Deubiquitinating Enzyme Cylindromatosis Dampens CD8+ T Cell Responses and Is a Critical Factor for Experimental Cerebral Malaria and Blood-Brain Barrier Damage |
| Q38614040 | The IKK Kinases: Operators of Antiviral Signaling |
| Q64924690 | The Many Roles of Ubiquitin in NF-κB Signaling. |
| Q42423390 | The NLRP4-DTX4 axis: a key suppressor of TBK1 and innate antiviral signaling. |
| Q92511672 | The Role of Deubiquitinases in Oncovirus and Host Interactions |
| Q58618043 | The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway |
| Q35076546 | The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase |
| Q36739316 | The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase |
| Q64288182 | The role of ubiquitin-specific peptidases in cancer progression |
| Q26853682 | The two faces of receptor interacting protein kinase-1 |
| Q34449547 | The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3. |
| Q39174910 | The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25 |
| Q33619601 | Toll-like receptor-mediated down-regulation of the deubiquitinase cylindromatosis (CYLD) protects macrophages from necroptosis in wild-derived mice |
| Q40607338 | Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner |
| Q37576705 | USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase |
| Q89575106 | USP27X negatively regulates antiviral signaling by deubiquitinating RIG-I |
| Q39345375 | USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6. |
| Q36760183 | USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. |
| Q83500371 | USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA |
| Q37327225 | Ubiquitin in NF-kappaB signaling. |
| Q26771789 | Ubiquitin in the activation and attenuation of innate antiviral immunity |
| Q26998711 | Ubiquitin in the immune system |
| Q26751376 | Ubiquitin signaling in immune responses |
| Q37926284 | Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. |
| Q36293630 | Ubiquitin-specific Protease 15 Negatively Regulates Virus-induced Type I Interferon Signaling via Catalytically-dependent and -independent Mechanisms |
| Q35049396 | Ubiquitin-specific proteases 25 negatively regulates virus-induced type I interferon signaling |
| Q36640618 | Ubiquitination in the antiviral immune response |
| Q38021448 | Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications |
| Q37424798 | Ubiquitylation in innate and adaptive immunity. |
| Q24298547 | Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response |
| Q35625506 | Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling |
| Q40051381 | Viral deubiquitinases: role in evasion of anti-viral innate immunity. |
| Q54996453 | Viruses Seen by Our Cells: The Role of Viral RNA Sensors. |
| Q54625736 | ZAPS electrifies RIG-I signaling. |
| Q24307928 | ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses |
| Q24311676 | cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms |
| Q52941418 | miR-526a regulates apoptotic cell growth in human carcinoma cells. |
Search more.